Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.

RSV is a highly contagious virus affecting the ... it may lead to more serious symptoms like Rapid or labored breathing Bluish skin secondary to shortage of oxygen (cyanosis) Apnea (cessation ...

New vaccines to prevent RSV help address the burden of RSV in older adults and help prevent infection in infants through the vaccination of pregnant individuals. RSV can affect the lower ...

blistering rashes that usually appear in a specific area of the body and last for 2 to 4 weeks.[8] Respiratory syncytial ...

Timely diagnosis of RSV is imperative for optimal patient management; by rapidly identifying RSV infection, health professionals can implement appropriate infection control measures while limiting ...

Influenza, RSV and SARS-CoV-2 are still the top three viruses to watch out for in the fall and winter, but several public health tools that have become available in the past year should help boost ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

Three months after revealing that its respiratory syncytial virus (RSV) preventive antibody clesrovimab had passed muster in a phase 2b/3 trial, Merck is putting numbers to the claim. Clesrovimab ...

A vaccination programme to protect newborn babies and older people against respiratory syncytial virus (RSV) is being rolled out in England, Wales and Northern Ireland on Monday, following a ...

Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting last year, fell by more than 70% year over year, in part due to narrower U.S. recommendations for ...

In years prior to the availability of an RSV vaccine, an estimated 60,000 to 160,000 RSV-associated hospitalizations and 6,000 to 10,000 RSV-associated deaths occurred annually among U.S. adults ...